Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02412865 · ClinicalTrials.gov registry record · NA
Quit4Baby Evaluation
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 505
- Enrollment target
NCT02412865 is a NA study that has completed, run by George Washington University. The registered enrollment target is 505 participants.
The verdict
NCT02412865, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 505 participants
- Enrollment target
Study Summary
The goal of this project is to evaluate the effectiveness (Phase II) of a text-based program to be called Quit4Baby to support smoking cessation efforts of pregnant women who smoke. In Phase II, Dr. Abroms will conduct a randomized clinical trial among 500 pregnant smokers who have been recruited from users of text4baby - the first large scale mobile health application in the United States. Developed and operated by Voxiva and Healthy Mothers, Healthy Babies (HMHB)-collaborators in this program -text4baby is a free national service that has enrolled more than 800,000 pregnant women and mothers of infants 0-1 nationwide and delivered more than 150 million health messages to them including messages encouraging them not to smoke during pregnancy and referring them to quit lines. Hypothesis 1: Pregnant smokers who receive quit4Baby + text4Baby will demonstrate higher levels of knowledge about the dangers of second hand smoke and the benefits of smoking cessation for mothers and their infants than text4baby only users. Hypothesis 2: Pregnant smokers who receive quit4baby + text4baby will report significantly higher rates of calling a quit line, discussions with their health provider and/or use of cessation counseling than those who receive Text4baby alone. Hypothesis 3: Pregnant smokers who receive quit4baby + text4baby will have significantly more favorable quitting outcomes compared with text4baby alone.
Interventions
- BEHAVIORAL Text4Baby
- BEHAVIORAL Quit4Baby
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02412865
The ClinicalTrials.gov registry entry for NCT02412865 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 505 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Text4Baby is the first listed.
NCT02412865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02412865 about?
NCT02412865 is a clinical study titled "Quit4Baby Evaluation". The goal of this project is to evaluate the effectiveness (Phase II) of a text-based program to be called Quit4Baby to support smoking cessation efforts of pregnant women who smoke. In Phase II, Dr. Abroms will conduct a randomized clinical trial among 500 pregnant smokers who have been recruited f...
What is the current status of trial NCT02412865?
This trial is currently completed. It is a NA study. The enrollment target is 505 participants. The study started on 2015-04.
What interventions are being tested in trial NCT02412865?
The interventions under investigation include: Text4Baby (BEHAVIORAL), Quit4Baby (BEHAVIORAL).
Who is sponsoring clinical trial NCT02412865?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.